All In Biotech

Free tool

FAERS Monitor: Renvela

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 022127 or its brand name (Renvela, Sevelamer Carbonate). Reports on generic versions are filed under their own applications.

Reports

11,505

Serious

5,643

49% of reports

Hospitalization

3,059

Death reported

1,228

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • constipation2,548
  • diarrhoea1,057
  • pruritus1,009
  • nausea819
  • chronic kidney disease676
  • end stage renal disease674
  • renal failure666
  • death628
  • vomiting533
  • acute kidney injury515
  • abdominal pain308
  • nephrogenic anaemia298
  • dyspnoea294
  • fatigue267
  • flatulence251

Reports by year received

View as table
YearReports
20084
200954
201074
2011165
2012239
20131,071
20143,605
2015890
2016678
2017875
2018824
2019790
2020487
2021368
2022277
2023262
2024273
2025355
2026214

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,042,654 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
nephrogenic anaemiaSignal298125.6111.934,363
end stage renal diseaseSignal67470.165.144,193
constipationSignal2,54821.620.949,971
chronic kidney diseaseSignal67616.415.29,710
renal failureSignal6669.28.64,872
flatulenceSignal2518.17.21,558
acute kidney injurySignal5156.25.72,234
pruritusSignal1,0094.84.53,090
diarrhoeaSignal1,0573.02.81,446
abdominal painSignal3082.42.2258
vomitingSignal5332.11.9302
nausea8191.91.8357
death6281.31.254
dyspnoea2940.90.81
fatigue2670.60.661

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.